Text Size:

Hypertension

Background

Recommended action

Lifestyle modification

First line treatment

Combination treatment

Compelling and possible indications/contraindications

Additional drug therapy

Referral guidelines

 

Background

Hypertension is a major cardiovascular risk factor which develops in the majority of people with diabetes. Hypertensive diabetic patients are also at increased risk of diabetes-specific complications including retinopathy and nephropathy. Both the UKPDS and the Hypertension Optimal Treatment (HOT) trial showed improved outcomes in patients assigned to lower blood pressure targets. The aims of treatment are:

  • To reduce systolic blood pressure to < 140mmHg
  • To reduce diastolic blood pressure to < 80mmHg
  • To reduce blood pressure to < 130/80mmHg if diabetes and CHD co-exist or if microalbuminuria present

 

Recommended Action

Blood Pressure

(mmHg)

Recommended Action

<140/80

Reassess annually.

141-199 / 81-99

Confirm by 3 readings over 3-4 weeks, then initiate treatment.

200-219 / 110-119

Confirm by 3 readings over 1-2 weeks then treat (unless malignant phase or hypertensive emergency - admit immediately).

>220/120

Treat immediately.

 

If hypertension confirmed

 

 

ECG

 

 

Fasting lipid profile

 

U&E

 

Urine - blood/protein

 

Treatment

 

 

See below

 

Follow up

 

Review monthly x 3 months

Then at 6 months

Then annually

Continue to advise on lifestyle measures

 

Specialist referral

 

Malignant hypertension/ hypertensive emergency

 

Evaluation of therapeutic problems

 

Investigation of underlying causes

 

Patients with resistant BP (>150/90 despite 3 or more agents)/

white coat hypertension/

pregnancy

 

Lifestyle Modification

  • Advise all patients to institute lifestyle measures aimed at controlling hypertension

  • Restrict alcohol - < 21units/week (men) or < 14 units/week (women)

  • Reduce salt (but caution re potassium in salt alternatives) and saturated fat intake, increase fruit and vegetables . Consider weight loss if BMI> 25. Avoid effervescent/soluble tablets and certain indigestion products - high in salt content

  • Recommend regular physical activity, stop smoking - consider motivation to quit, referral to smoking cessation service, NRT, bupropion

 

First line treatment

  • Use ACE inhibitors as first line therapy in people with diabetes, especially if also have microalbuminuria or nephropathy. Treat blood pressure aggressively in people with diabetes. Multiple therapy often required

  • Use angiotensin II antagonists as the first choice alternative if ACE inhibitors are not tolerated. Choice of other first line medication will depend on relative indications and contra-indications in the individual patient (see below)

 

Combination Treatment

  • Two or more agents are generally required to achieve blood pressure targets. Useful combinations are:

  • An ACE inhibitor or ARB combined with a thiazide or loop diuretic

  • An ACE inhibitor combined with an ARB (but check for hyperkalaemia)

  • A calcium antagonist or beta blocker or alpha blocker as a third agent

 

Compelling and possible indications/contraindications

Class of Drug

Compelling Indications

Possible Indications

Possible Contraindications

Compelling Contraindications

Thiazides-

Bendrofluazide 2.5mg

Elderly patients

(including ISH)

 

Dyslipidaemia

Gout

Loop diuretics

Furosemide

Oedema

Impaired renal function

Heart failure

 

Pregnancy

Breast feeding

Hypovolaemia

Cirrhosis

Anuria

Potassium sparing diuretics

Spironolactone

CCF

Oedema in Cirrhosis

Nephrotic syndrome

Limit potassium loss with thiazide diuretics

Impaired renal function

 

Beta-blockers -

Atenolol

 

Myocardial infarction

Angina

Heart failure ***

(Bisoprolol)

Heart failure ***

Dyslipidaemia

Peripheral Vascular Disease

Asthma/COAD

Heart block

Calcium antagonists (Dihydropyridine) - Felodipine/ Adalat LA/ Amlodipine

Elderly ISH

Elderly

Angina

 

 

 

 

 

 

 

ACE-inhibitors -

Lisinopril

Ramipril

Perindopril

Fosinopril

Heart failure

LV dysfunction

Type 1 diabetic nephropathy

Chronic renal disease *

Type 2 diabetic

nephropathy

Renal impairment

Peripheral Vascular Disease (PVD) **

Aortic stenosis

Pregnancy

Renovascular disease

Calcium antagonists

(rate-limiting) - Verapamil / Diltiazem

Angina

Myocardial Infarction

Combination with beta blockade

Heart block

Heart failure

Alpha-blockers - Doxazosin/ Prazosin

Prostatism

Dyslipidaemia

Postural hypotension

Urinary incontinence

Angiotensin receptor blockers- (ARB's)

Irbesartan

Valsartan

Losartan

To be used where ACE inhibitors are indicated, but cannot be tolerated

Heart failure

Intolerance of other antihypertensive drugs

PVD **

Pregnancy

Renovascular disease

* ACE inhibitors may be beneficial in chronic renal failure but should be used with caution. Close supervision and specialist advice is needed when there is established and significant renal impairment.
** Caution with ACE inhibitors and angiotensin 11 receptor antagonists in peripheral vascular disease because of association with renovascular disease.
*** Beta-blockers may worsen heart failure, but in specialist hands may be used to treat heart failure

 

Additional drug therapy

  • Aspirin 75mg daily should be added once the BP has ben brought down to <150/90

  • Lipid lowering therapy may also be required

 

Referral

  • If BP>150 systolic or >90 diastolic despite 3 or more agents refer to the hospital diabetic clinic